Drive DeVilbiss Healthcare, headquartered in the United States, is a leading provider in the healthcare industry, specialising in innovative medical products and solutions. Founded in 1888, the company has established a strong presence across North America, Europe, and Asia, focusing on enhancing patient care through its diverse range of offerings. The company’s core products include mobility aids, respiratory equipment, and sleep therapy devices, all designed with a commitment to quality and user-centric design. Drive DeVilbiss Healthcare is recognised for its unique blend of advanced technology and practical functionality, ensuring that patients receive the best possible support. With a robust market position, Drive DeVilbiss Healthcare has achieved numerous accolades for its contributions to the healthcare sector, solidifying its reputation as a trusted partner for healthcare professionals and patients alike.
How does Drive DeVilbiss Healthcare's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Metal Fabrication industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Drive DeVilbiss Healthcare's score of 17 is lower than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Drive DeVilbiss Healthcare reported total carbon emissions of approximately 3,482,000 kg CO2e. This figure includes 1,463,000 kg CO2e from Scope 1 emissions, primarily from mobile combustion, and 1,649,000 kg CO2e from Scope 2 emissions. Additionally, the company recorded 402,000 kg CO2e in Scope 3 emissions, specifically from purchased goods and services. Comparatively, in 2023, the total emissions were about 3,337,000 kg CO2e, with Scope 1 emissions at 1,512,000 kg CO2e and Scope 2 emissions at 1,825,000 kg CO2e. The trend indicates a slight increase in emissions year-on-year. Drive DeVilbiss Healthcare has set ambitious climate commitments, aiming to reduce Scope 1 and Scope 2 emissions by at least 10% by 2030, with a target start year of 2022. Furthermore, the company is committed to achieving Net Zero carbon emissions by 2050, reflecting a long-term strategy to mitigate climate impact. The emissions data is cascaded from its parent company, Medical Depot, Inc., which influences its overall carbon footprint and sustainability initiatives.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Drive DeVilbiss Healthcare has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
